Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | SLC1A3 | P43003 | 1/20 | 1.00 |
| ▸ | SLC1A2 | P43004 | 1/20 | 1.00 |
| ▸ | SLC1A1 | P43005 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | ARG1 | P05089 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GABRP | O00591 | 1/20 | 0.37 |
| ▸ | GABRD | O14764 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2559376 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL8480461 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL12648650 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL8480462 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL2808482 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL2484170 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL542244 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL17743411 | 0.98 | CYP2D6 (0.95) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL21402235 | 0.98 | CYP2D6 (0.95) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL6652332 | 0.86 | CYP2D6 (0.75) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118539490-A | Multi-objective operation optimization control method and device for optical storage and charging micro-grid | 电力规划总院有限公司 | 2024-08-23 | — | — | CN | claimed |
| US-20230136218-A1 | METHODS AND COMPOSITIONS FOR TREATING ACUTE MYELOID LEUKEMIA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-05-04 | — | — | US | claimed |
| WO-2023023538-A2 | TREATING TISSUE INFLAMMATION | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2023-02-23 | — | — | WO | claimed |
| CN-114010633-A | Application of glutamate transporter inhibitor in preparation of medicine for preventing and treating chronic hypoperfusion brain injury | 廖儒佳 | 2022-02-08 | — | — | CN | claimed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-8053585-B2 | Protecting group for carboxylic acids that can be photolyzed by visible light | CORNELL RESEARCH FOUNDATION, INC. (US) | 2011-11-08 | — | — | US | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| US-20070243519-A1 | Protecting group for carboxylic acids that can be photolyzed by visible light | CORNELL RESEARCH FOUNDATION, INC. (US) | 2007-10-18 | — | — | US | claimed |
| WO-2000027374-B1 | THE USE OF EXCITATORY AMINO ACID TRANSPORTER INHIBITORS TO REDUCE CNS WHITE MATTER INJURY | LOEB HEALTH INST AT THE OTTAWA (CA) | 2001-06-21 | — | — | WO | claimed |
| WO-2000027374-A2 | THE USE OF EXCITATORY AMINO ACID TRANSPORTER INHIBITORS TO REDUCE CNS WHITE MATTER INJURY | LOEB HEALTH INSTITUTE AT THE OTTAWA HOSPITAL (CA) | 2000-05-18 | — | — | WO | claimed |
| US-5587509-A | Caged caboxyl compounds and use thereof | CORNELL RESEARCH FOUNDATION, INC. (US) | 1996-12-24 | — | — | US | claimed |
| US-5430175-A | Caged carboxyl compounds and use thereof | CORNELL RESEARCH FOUNDATION, INC. (US) | 1995-07-04 | — | — | US | claimed |
| WO-1995015305-A1 | CAGED CARVOXYL COMPOUNDS AND THEIR USE IN CHEMICAL KINETIC INVESTIGATION OF NEUROTRANSMITTER RECEPTORS | CORNELL RESEARCH FOUNDATION, INC. (US) | 1995-06-08 | — | — | WO | claimed |
| US-20250032635-A1 | LIGAND-POLAR DRUG CONJUGATES | TRIPARTITE THERAPEUTICS INC. (TW) | 2025-01-30 | — | — | US | disclosed |
| EP-4291301-B1 | NON-INVASIVE CANCER TREATMENT | SCIENTIA BIOTECH S L (ES) | 2025-01-15 | — | — | EP | disclosed |
| CN-118539490-A | Multi-objective operation optimization control method and device for optical storage and charging micro-grid | 电力规划总院有限公司 | 2024-08-23 | — | — | CN | disclosed |
| US-5658782-A | AN ISOLATED NUCLEIC ACID COMPRISING A NUCLEOTIDE SEQUENCE ENCODING A HUMAN EXCITATORY AMINO ACID TRANSPORTER PROTEIN; GENETIC ENGINEERING | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY A NON-PROFIT ORGANIZATION (US) | 1997-08-19 | — | — | US | disclosed |
| WO-1997022251-A1 | COMPOSITIONS FOR MODULATING INTRACELLULAR INOSITOL TRISPHOSPHATE CONCENTRATION AND USES THEREOF | AYURCORE, INC. (US) | 1997-06-26 | — | — | WO | disclosed |
| WO-1995015305-A1 | CAGED CARVOXYL COMPOUNDS AND THEIR USE IN CHEMICAL KINETIC INVESTIGATION OF NEUROTRANSMITTER RECEPTORS | CORNELL RESEARCH FOUNDATION, INC. (US) | 1995-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | CYP2D6 3808/4885CYP1A2 3261/4885ALOX15 914/4885 |
| US-20250032635-A1 | LIGAND-POLAR DRUG CONJUGATES | CD274, SELPLG, PDCD1LG2 | CYP2D6 112/4885CYP1A2 592/4885ALOX15 836/4885 |
| US-20070243519-A1 | Protecting group for carboxylic acids that can be photolyzed by visible light | CYBA, ALDH3A1, HCCS | CYP2D6 630/4885CYP1A2 578/4885ALOX15 1049/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | CYP2D6 2307/4885CYP1A2 1104/4885ALOX15 383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.